Feasibility Study for Implementing Disease‐Modifying Therapies in Alzheimer's Disease: Process Measures and Patient Pathways across Ireland

This feasibility study addresses the critical need for preparedness in integrating DMTs for AD, which were recently approved in Europe but remain underutilized due to systemic barriers. By generating actionable insights and laying the groundwork for national guidelines, this project not only advances Ireland's readiness but also serves as a model for other European countries seeking to adopt transformative therapies for Alzheimer's disease.